ArticleHepatology (Baltimore, Md.)2025

Radiomics beyond the visible-Decoding tumor heterogeneity to guide combination therapy of intermediate-stage HCC.

William Lotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.